IM Cannabis (IMCC) Accounts Payables (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Accounts Payables of $6.0 million for Q1 2026, down 46.47% year-over-year from $11.2 million in Q1 2025, and down 30.8% quarter-over-quarter from $8.6 million in Q4 2025.
IM Cannabis (IMCC) Accounts Payables (2019 - 2026) Analysis & Trends
IM Cannabis' Accounts Payables history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 46.47% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (down 46.47% YoY), while the FY2025 annual figure was $8.6 million, up 6.06% from the prior year.
- Accounts Payables for Q1 2026 stood at $6.0 million, down from $8.6 million in the prior quarter.
- The five-year high for Accounts Payables was $12.1 million in Q3 2024, with the low at $5.2 million in Q3 2025.
- The 5-year median for Accounts Payables is $8.6 million (2025), against an average of $8.8 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 204.67% in 2022, then sank 57.24% in 2025.
- IM Cannabis' Accounts Payables stood at $11.3 million in 2022, then slumped by 39.94% to $6.8 million in 2023, then rose by 17.91% to $8.0 million in 2024, then climbed by 8.22% to $8.6 million in 2025, then sank by 30.8% to $6.0 million in 2026.
- Business Quant data shows IMCC's Accounts Payables at $6.0 million in Q1 2026, $8.6 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 6.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.12 Mn |
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 8.64 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 8.78 Mn |
| Mar 31, 2025 | 11.18 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Sep 30, 2024 | 12.14 Mn |
| Jun 30, 2024 | 10.15 Mn |
| Mar 31, 2024 | 7.06 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Jun 30, 2023 | 6.98 Mn |
| Mar 31, 2023 | 6.83 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Sep 30, 2022 | 9.03 Mn |
| Jun 30, 2022 | 11.92 Mn |
| Mar 31, 2022 | 11.90 Mn |
| Dec 31, 2021 | 3.70 Mn |
| Dec 31, 2020 | 2.00 Mn |